HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gary R Duckwiler Selected Research
Gary R Duckwiler Research Topics
Disease
17
Ischemic Stroke
01/2018 - 06/2003
12
Stroke (Strokes)
10/2022 - 06/2003
8
Aneurysm (Aneurysms)
10/2023 - 01/2003
8
Brain Ischemia (Cerebral Ischemia)
03/2017 - 12/2004
6
Intracranial Aneurysm (Cerebral Aneurysm)
02/2017 - 04/2002
5
Hemorrhage
01/2022 - 04/2007
4
Pathologic Constriction (Stenosis)
10/2023 - 04/2002
4
Embolism (Embolus)
07/2014 - 12/2004
3
Arterial Occlusive Diseases (Arterial Occlusive Disease)
02/2016 - 05/2010
3
Thrombosis (Thrombus)
06/2015 - 04/2002
2
Epistaxis (Nosebleed)
10/2023 - 01/2022
2
Arteriovenous Malformations (Arteriovenous Malformation)
01/2021 - 02/2017
2
Arteriovenous Fistula
02/2017 - 06/2006
2
Hematoma
07/2012 - 02/2012
2
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2012 - 12/2010
2
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2010 - 11/2006
2
Infarction (Infarctions)
05/2010 - 10/2009
1
Varicose Veins (Varicose Vein)
01/2023
1
Intracranial Sinus Thrombosis (Sinus Thrombosis)
02/2020
1
Ischemia
01/2019
1
Blindness (Hysterical Blindness)
01/2019
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2018
1
Neurologic Manifestations (Neurological Manifestations)
03/2017
1
Neoplasms (Cancer)
02/2017
1
Rupture
06/2016
1
Leukoaraiosis
07/2012
1
Vertebrobasilar Insufficiency
02/2012
1
Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
01/2012
1
Hypertension (High Blood Pressure)
12/2010
1
Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
10/2010
1
Cerebral Infarction
05/2010
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2009
1
Cerebral Hemorrhage
01/2009
1
Hyperlipidemias (Hyperlipidemia)
01/2009
Drug/Important Bio-Agent (IBA)
3
Tissue Plasminogen Activator (Alteplase)
FDA Link
10/2022 - 06/2003
2
Indicators and Reagents (Reagents)
IBA
02/2012 - 11/2003
2
Phenobarbital (Luminal)
FDA Link
01/2012 - 05/2010
1
Sclerosing Solutions (Sclerosing Agents)
IBA
01/2023
1
Iron
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
Doxycycline (Periostat)
FDA Link
Generic
01/2022
1
Hyaluronoglucosaminidase (Hyaluronidase)
FDA Link
01/2019
1
Retinaldehyde (Retinal)
IBA
01/2019
1
Hyaluronic Acid (Hyaluronan)
IBA
01/2019
1
Platinum
IBA
02/2017
1
Warfarin (Coumadin)
FDA Link
Generic
01/2012
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2012
1
antineoplaston A10 (A 10)
IBA
01/2012
1
Enbucrilate
IBA
10/2010
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2009
1
3-hydroxy-7-methylcholanoic acid (HMCA)
IBA
11/2003
1
Papaverine
IBA
01/2003
1
Abciximab (ReoPro)
FDA Link
04/2002
Therapy/Procedure
16
Therapeutics
10/2022 - 04/2002
15
Thrombectomy
01/2018 - 04/2007
6
Stents
06/2016 - 04/2002
4
Endovascular Procedures
10/2023 - 01/2009
3
Ligation
10/2023 - 06/2006
3
Catheters
10/2023 - 11/2003
2
Cerebral Revascularization
10/2023 - 12/2009
2
Embolectomy
01/2009 - 12/2004
1
Blood Transfusion (Blood Transfusions)
01/2022
1
Therapeutic Embolization
01/2021
1
Off-Label Use
01/2012
1
Length of Stay
10/2009
1
Retreatment
01/2008
1
Aftercare (After-Treatment)
01/2008
1
Intravenous Infusions
04/2002